Question 1

How many shares of CLDX does SUSQUEHANNA INTERNATIONAL GROUP, LLP own?

Accepted Answer

As of 2026-Q2, SUSQUEHANNA INTERNATIONAL GROUP, LLP holds 19,080 shares of CLDX (Celldex Therapeutics, Inc.).

Question 2

What is SUSQUEHANNA INTERNATIONAL GROUP, LLP's CLDX position worth?

Accepted Answer

As of 2026-Q2, SUSQUEHANNA INTERNATIONAL GROUP, LLP's CLDX position is worth $709,967.

Question 3

Is SUSQUEHANNA INTERNATIONAL GROUP, LLP buying or selling CLDX?

Accepted Answer

In 2026-Q2, SUSQUEHANNA INTERNATIONAL GROUP, LLP decreased their CLDX position (-46.9% change in shares).

Question 4

When did SUSQUEHANNA INTERNATIONAL GROUP, LLP first buy CLDX?

Accepted Answer

Based on available 13F filings, SUSQUEHANNA INTERNATIONAL GROUP, LLP first reported a position in CLDX in 2024-Q3. They have held the position across 31 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	19,080	-46.9%	$709,967	0.0%	$37.21	0
2026-Q1	New	35,948	—	$1.1M	0.0%	$28.94	35
2025-Q4	Exited	0	-100.0%	$0	0.0%	$26.43	0
2025-Q3	Decreased	27,367	-75.4%	$707,984	0.0%	$26.19	0
2025-Q2	Increased	111,399	+18.9%	$2.3M	0.0%	$20.29	31
2025-Q1	Increased	93,670	+41.9%	$1.7M	0.0%	$19.93	34
2024-Q4	Increased	66,034	+2.3%	$1.7M	0.0%	$25.12	26
2024-Q3	Increased	64,576	+35.0%	$2.2M	0.0%	$33.20	34